APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oseltamivir Phosphate Antiviral Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Oseltamivir Phosphate Antiviral Drug Market Analysis and Forecast 2026-2032

21 December 2025208 pages

Choose your research edition.

Industry ResearchOseltamivir Phosphate Antiviral Drug Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Oseltamivir Phosphate Antiviral Drug Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Oseltamivir Phosphate Antiviral Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oseltamivir Phosphate Antiviral Drug Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Oseltamivir Phosphate Antiviral Drug Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Oseltamivir Phosphate Antiviral Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Oseltamivir Phosphate Antiviral Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Oseltamivir Phosphate Antiviral Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Oseltamivir Phosphate Antiviral Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Oseltamivir Phosphate Antiviral Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Oseltamivir Phosphate Antiviral Drug include Teva Pharmaceuticals, SL Pharmaceutica, Cspc Holdings, Roche Group, Kelun Pharmaceutical, HEC ChangJiang Pharmaceutical, BrightGene Bio-Medical Technology, Zydus Cadila and Strides Pharma Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Oseltamivir Phosphate Antiviral Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Oseltamivir Phosphate Antiviral Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Oseltamivir Phosphate Antiviral Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oseltamivir Phosphate Antiviral Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Oseltamivir Phosphate Antiviral Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Oseltamivir Phosphate Antiviral Drug sales, projected growth trends, production technology, application and end-user industry.

Oseltamivir Phosphate Antiviral Drug Segment by Company

Teva Pharmaceuticals

SL Pharmaceutica

Cspc Holdings

Roche Group

Kelun Pharmaceutical

HEC ChangJiang Pharmaceutical

BrightGene Bio-Medical Technology

Zydus Cadila

Strides Pharma Inc.

Novadoz

Natco Pharma

Macleods Pharmaceuticals

LUPINE Limited

Hetero Group

Camber Pharmaceuticals

Amneal Pharmaceuticals

Alvogen

Alembic Pharmaceuticals

Ajanta Pharma

Oseltamivir Phosphate Antiviral Drug Segment by Type

Capsule

Suspension

Oseltamivir Phosphate Antiviral Drug Segment by Application

Child

Aldult

Oseltamivir Phosphate Antiviral Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oseltamivir Phosphate Antiviral Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oseltamivir Phosphate Antiviral Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oseltamivir Phosphate Antiviral Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Oseltamivir Phosphate Antiviral Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Oseltamivir Phosphate Antiviral Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oseltamivir Phosphate Antiviral Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Oseltamivir Phosphate Antiviral Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Capsule Major Manufacturers Table 3. Suspension Major Manufacturers Table 4. Global Oseltamivir Phosphate Antiviral Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Child Major Manufacturers Table 6. Aldult Major Manufacturers Table 7. Oseltamivir Phosphate Antiviral Drug Industry Trends Table 8. Oseltamivir Phosphate Antiviral Drug Industry Drivers Table 9. Oseltamivir Phosphate Antiviral Drug Industry Opportunities and Challenges Table 10. Oseltamivir Phosphate Antiviral Drug Industry Restraints Table 11. Global Oseltamivir Phosphate Antiviral Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Oseltamivir Phosphate Antiviral Drug Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Oseltamivir Phosphate Antiviral Drug Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Region (2021-2026) Table 15. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Region (2027-2032) Table 16. Global Oseltamivir Phosphate Antiviral Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global Oseltamivir Phosphate Antiviral Drug Sales by Region (2021-2026) & (k units) Table 18. Global Oseltamivir Phosphate Antiviral Drug Sales by Region (2027-2032) & (k units) Table 19. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Region (2021-2026) Table 20. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Region (2027-2032) Table 21. Global Oseltamivir Phosphate Antiviral Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Oseltamivir Phosphate Antiviral Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Manufacturers (2021-2026) Table 25. Global Oseltamivir Phosphate Antiviral Drug Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global Oseltamivir Phosphate Antiviral Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Oseltamivir Phosphate Antiviral Drug Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Oseltamivir Phosphate Antiviral Drug Manufacturers, Product Type & Application Table 29. Global Oseltamivir Phosphate Antiviral Drug Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Oseltamivir Phosphate Antiviral Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Oseltamivir Phosphate Antiviral Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Oseltamivir Phosphate Antiviral Drug Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Oseltamivir Phosphate Antiviral Drug Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Type (2021-2026) Table 36. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Type (2027-2032) Table 37. Global Oseltamivir Phosphate Antiviral Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global Oseltamivir Phosphate Antiviral Drug Sales by Type (2021-2026) & (k units) Table 39. Global Oseltamivir Phosphate Antiviral Drug Sales by Type (2027-2032) & (k units) Table 40. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Type (2021-2026) Table 41. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Type (2027-2032) Table 42. Global Oseltamivir Phosphate Antiviral Drug Price by Type (2021-2026) & (US$/unit) Table 43. Global Oseltamivir Phosphate Antiviral Drug Price by Type (2027-2032) & (US$/unit) Table 44. Global Oseltamivir Phosphate Antiviral Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Oseltamivir Phosphate Antiviral Drug Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Oseltamivir Phosphate Antiviral Drug Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Application (2021-2026) Table 48. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Application (2027-2032) Table 49. Global Oseltamivir Phosphate Antiviral Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global Oseltamivir Phosphate Antiviral Drug Sales by Application (2021-2026) & (k units) Table 51. Global Oseltamivir Phosphate Antiviral Drug Sales by Application (2027-2032) & (k units) Table 52. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Application (2021-2026) Table 53. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Application (2027-2032) Table 54. Global Oseltamivir Phosphate Antiviral Drug Price by Application (2021-2026) & (US$/unit) Table 55. Global Oseltamivir Phosphate Antiviral Drug Price by Application (2027-2032) & (US$/unit) Table 56. Teva Pharmaceuticals Company Information Table 57. Teva Pharmaceuticals Business Overview Table 58. Teva Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. Teva Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 60. Teva Pharmaceuticals Recent Development Table 61. SL Pharmaceutica Company Information Table 62. SL Pharmaceutica Business Overview Table 63. SL Pharmaceutica Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. SL Pharmaceutica Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 65. SL Pharmaceutica Recent Development Table 66. Cspc Holdings Company Information Table 67. Cspc Holdings Business Overview Table 68. Cspc Holdings Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Cspc Holdings Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 70. Cspc Holdings Recent Development Table 71. Roche Group Company Information Table 72. Roche Group Business Overview Table 73. Roche Group Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Roche Group Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 75. Roche Group Recent Development Table 76. Kelun Pharmaceutical Company Information Table 77. Kelun Pharmaceutical Business Overview Table 78. Kelun Pharmaceutical Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Kelun Pharmaceutical Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 80. Kelun Pharmaceutical Recent Development Table 81. HEC ChangJiang Pharmaceutical Company Information Table 82. HEC ChangJiang Pharmaceutical Business Overview Table 83. HEC ChangJiang Pharmaceutical Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. HEC ChangJiang Pharmaceutical Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 85. HEC ChangJiang Pharmaceutical Recent Development Table 86. BrightGene Bio-Medical Technology Company Information Table 87. BrightGene Bio-Medical Technology Business Overview Table 88. BrightGene Bio-Medical Technology Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. BrightGene Bio-Medical Technology Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 90. BrightGene Bio-Medical Technology Recent Development Table 91. Zydus Cadila Company Information Table 92. Zydus Cadila Business Overview Table 93. Zydus Cadila Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Zydus Cadila Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 95. Zydus Cadila Recent Development Table 96. Strides Pharma Inc. Company Information Table 97. Strides Pharma Inc. Business Overview Table 98. Strides Pharma Inc. Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Strides Pharma Inc. Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 100. Strides Pharma Inc. Recent Development Table 101. Novadoz Company Information Table 102. Novadoz Business Overview Table 103. Novadoz Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Novadoz Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 105. Novadoz Recent Development Table 106. Natco Pharma Company Information Table 107. Natco Pharma Business Overview Table 108. Natco Pharma Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Natco Pharma Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 110. Natco Pharma Recent Development Table 111. Macleods Pharmaceuticals Company Information Table 112. Macleods Pharmaceuticals Business Overview Table 113. Macleods Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Macleods Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 115. Macleods Pharmaceuticals Recent Development Table 116. LUPINE Limited Company Information Table 117. LUPINE Limited Business Overview Table 118. LUPINE Limited Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. LUPINE Limited Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 120. LUPINE Limited Recent Development Table 121. Hetero Group Company Information Table 122. Hetero Group Business Overview Table 123. Hetero Group Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Hetero Group Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 125. Hetero Group Recent Development Table 126. Camber Pharmaceuticals Company Information Table 127. Camber Pharmaceuticals Business Overview Table 128. Camber Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Camber Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 130. Camber Pharmaceuticals Recent Development Table 131. Amneal Pharmaceuticals Company Information Table 132. Amneal Pharmaceuticals Business Overview Table 133. Amneal Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Amneal Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 135. Amneal Pharmaceuticals Recent Development Table 136. Alvogen Company Information Table 137. Alvogen Business Overview Table 138. Alvogen Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. Alvogen Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 140. Alvogen Recent Development Table 141. Alembic Pharmaceuticals Company Information Table 142. Alembic Pharmaceuticals Business Overview Table 143. Alembic Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 144. Alembic Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 145. Alembic Pharmaceuticals Recent Development Table 146. Ajanta Pharma Company Information Table 147. Ajanta Pharma Business Overview Table 148. Ajanta Pharma Oseltamivir Phosphate Antiviral Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 149. Ajanta Pharma Oseltamivir Phosphate Antiviral Drug Product Portfolio Table 150. Ajanta Pharma Recent Development Table 151. North America Oseltamivir Phosphate Antiviral Drug Revenue by Type (2021-2026) & (US$ Million) Table 152. North America Oseltamivir Phosphate Antiviral Drug Revenue by Type (2027-2032) & (US$ Million) Table 153. North America Oseltamivir Phosphate Antiviral Drug Sales by Type (2021-2026) & (k units) Table 154. North America Oseltamivir Phosphate Antiviral Drug Sales by Type (2027-2032) & (k units) Table 155. North America Oseltamivir Phosphate Antiviral Drug Sales Price by Type (2021-2026) & (US$/unit) Table 156. North America Oseltamivir Phosphate Antiviral Drug Sales Price by Type (2027-2032) & (US$/unit) Table 157. North America Oseltamivir Phosphate Antiviral Drug Revenue by Application (2021-2026) & (US$ Million) Table 158. North America Oseltamivir Phosphate Antiviral Drug Revenue by Application (2027-2032) & (US$ Million) Table 159. North America Oseltamivir Phosphate Antiviral Drug Sales by Application (2021-2026) & (k units) Table 160. North America Oseltamivir Phosphate Antiviral Drug Sales by Application (2027-2032) & (k units) Table 161. North America Oseltamivir Phosphate Antiviral Drug Sales Price by Application (2021-2026) & (US$/unit) Table 162. North America Oseltamivir Phosphate Antiviral Drug Sales Price by Application (2027-2032) & (US$/unit) Table 163. North America Oseltamivir Phosphate Antiviral Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. North America Oseltamivir Phosphate Antiviral Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 165. North America Oseltamivir Phosphate Antiviral Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 166. North America Oseltamivir Phosphate Antiviral Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 167. North America Oseltamivir Phosphate Antiviral Drug Sales by Country (2021-2026) & (k units) Table 168. North America Oseltamivir Phosphate Antiviral Drug Sales by Country (2027-2032) & (k units) Table 169. North America Oseltamivir Phosphate Antiviral Drug Sales Price by Country (2021-2026) & (US$/unit) Table 170. North America Oseltamivir Phosphate Antiviral Drug Sales Price by Country (2027-2032) & (US$/unit) Table 171. United States Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Table 172. Canada Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Table 173. Mexico Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Table 174. Europe Oseltamivir Phosphate Antiviral Drug Revenue by Type (2021-2026) & (US$ Million) Table 175. Europe Oseltamivir Phosphate Antiviral Drug Revenue by Type (2027-2032) & (US$ Million) Table 176. Europe Oseltamivir Phosphate Antiviral Drug Sales by Type (2021-2026) & (k units) Table 177. Europe Oseltamivir Phosphate Antiviral Drug Sales by Type (2027-2032) & (k units) Table 178. Europe Oseltamivir Phosphate Antiviral Drug Sales Price by Type (2021-2026) & (US$/unit) Table 179. Europe Oseltamivir Phosphate Antiviral Drug Sales Price by Type (2027-2032) & (US$/unit) Table 180. Europe Oseltamivir Phosphate Antiviral Drug Revenue by Application (2021-2026) & (US$ Million) Table 181. Europe Oseltamivir Phosphate Antiviral Drug Revenue by Application (2027-2032) & (US$ Million) Table 182. Europe Oseltamivir Phosphate Antiviral Drug Sales by Application (2021-2026) & (k units) Table 183. Europe Oseltamivir Phosphate Antiviral Drug Sales by Application (2027-2032) & (k units) Table 184. Europe Oseltamivir Phosphate Antiviral Drug Sales Price by Application (2021-2026) & (US$/unit) Table 185. Europe Oseltamivir Phosphate Antiviral Drug Sales Price by Application (2027-2032) & (US$/unit) Table 186. Europe Oseltamivir Phosphate Antiviral Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 187. Europe Oseltamivir Phosphate Antiviral Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 188. Europe Oseltamivir Phosphate Antiviral Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 189. Europe Oseltamivir Phosphate Antiviral Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 190. Europe Oseltamivir Phosphate Antiviral Drug Sales by Country (2021-2026) & (k units) Table 191. Europe Oseltamivir Phosphate Antiviral Drug Sales by Country (2027-2032) & (k units) Table 192. Europe Oseltamivir Phosphate Antiviral Drug Sales Price by Country (2021-2026) & (US$/unit) Table 193. Europe Oseltamivir Phosphate Antiviral Drug Sales Price by Country (2027-2032) & (US$/unit) Table 194. Germany Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Table 195. France Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Table 196. U.K. Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Table 197. Italy Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Table 198. Russia Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Table 199. Spain Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Table 200. Netherlands Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Table 201. Switzerland Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Table 202. Sweden Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Table 203. Poland Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Table 204. China Oseltamivir Phosphate Antiviral Drug Revenue by Type (2021-2026) & (US$ Million) Table 205. China Oseltamivir Phosphate Antiviral Drug Revenue by Type (2027-2032) & (US$ Million) Table 206. China Oseltamivir Phosphate Antiviral Drug Sales by Type (2021-2026) & (k units) Table 207. China Oseltamivir Phosphate Antiviral Drug Sales by Type (2027-2032) & (k units) Table 208. China Oseltamivir Phosphate Antiviral Drug Sales Price by Type (2021-2026) & (US$/unit) Table 209. China Oseltamivir Phosphate Antiviral Drug Sales Price by Type (2027-2032) & (US$/unit) Table 210. China Oseltamivir Phosphate Antiviral Drug Revenue by Application (2021-2026) & (US$ Million) Table 211. China Oseltamivir Phosphate Antiviral Drug Revenue by Application (2027-2032) & (US$ Million) Table 212. China Oseltamivir Phosphate Antiviral Drug Sales by Application (2021-2026) & (k units) Table 213. China Oseltamivir Phosphate Antiviral Drug Sales by Application (2027-2032) & (k units) Table 214. China Oseltamivir Phosphate Antiviral Drug Sales Price by Application (2021-2026) & (US$/unit) Table 215. China Oseltamivir Phosphate Antiviral Drug Sales Price by Application (2027-2032) & (US$/unit) Table 216. Asia Oseltamivir Phosphate Antiviral Drug Revenue by Type (2021-2026) & (US$ Million) Table 217. Asia Oseltamivir Phosphate Antiviral Drug Revenue by Type (2027-2032) & (US$ Million) Table 218. Asia Oseltamivir Phosphate Antiviral Drug Sales by Type (2021-2026) & (k units) Table 219. Asia Oseltamivir Phosphate Antiviral Drug Sales by Type (2027-2032) & (k units) Table 220. Asia Oseltamivir Phosphate Antiviral Drug Sales Price by Type (2021-2026) & (US$/unit) Table 221. Asia Oseltamivir Phosphate Antiviral Drug Sales Price by Type (2027-2032) & (US$/unit) Table 222. Asia Oseltamivir Phosphate Antiviral Drug Revenue by Application (2021-2026) & (US$ Million) Table 223. Asia Oseltamivir Phosphate Antiviral Drug Revenue by Application (2027-2032) & (US$ Million) Table 224. Asia Oseltamivir Phosphate Antiviral Drug Sales by Application (2021-2026) & (k units) Table 225. Asia Oseltamivir Phosphate Antiviral Drug Sales by Application (2027-2032) & (k units) Table 226. Asia Oseltamivir Phosphate Antiviral Drug Sales Price by Application (2021-2026) & (US$/unit) Table 227. Asia Oseltamivir Phosphate Antiviral Drug Sales Price by Application (2027-2032) & (US$/unit) Table 228. Asia Oseltamivir Phosphate Antiviral Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 229. Asia Oseltamivir Phosphate Antiviral Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 230. Asia Oseltamivir Phosphate Antiviral Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 231. Asia Oseltamivir Phosphate Antiviral Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 232. Asia Oseltamivir Phosphate Antiviral Drug Sales by Country (2021-2026) & (k units) Table 233. Asia Oseltamivir Phosphate Antiviral Drug Sales by Country (2027-2032) & (k units) Table 234. Asia Oseltamivir Phosphate Antiviral Drug Sales Price by Country (2021-2026) & (US$/unit) Table 235. Asia Oseltamivir Phosphate Antiviral Drug Sales Price by Country (2027-2032) & (US$/unit) Table 236. Japan Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Table 237. South Korea Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Table 238. India Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Table 239. Australia Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Table 240. Taiwan Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Table 241. Southeast Asia Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Table 242. SAMEA Oseltamivir Phosphate Antiviral Drug Revenue by Type (2021-2026) & (US$ Million) Table 243. SAMEA Oseltamivir Phosphate Antiviral Drug Revenue by Type (2027-2032) & (US$ Million) Table 244. SAMEA Oseltamivir Phosphate Antiviral Drug Sales by Type (2021-2026) & (k units) Table 245. SAMEA Oseltamivir Phosphate Antiviral Drug Sales by Type (2027-2032) & (k units) Table 246. SAMEA Oseltamivir Phosphate Antiviral Drug Sales Price by Type (2021-2026) & (US$/unit) Table 247. SAMEA Oseltamivir Phosphate Antiviral Drug Sales Price by Type (2027-2032) & (US$/unit) Table 248. SAMEA Oseltamivir Phosphate Antiviral Drug Revenue by Application (2021-2026) & (US$ Million) Table 249. SAMEA Oseltamivir Phosphate Antiviral Drug Revenue by Application (2027-2032) & (US$ Million) Table 250. SAMEA Oseltamivir Phosphate Antiviral Drug Sales by Application (2021-2026) & (k units) Table 251. SAMEA Oseltamivir Phosphate Antiviral Drug Sales by Application (2027-2032) & (k units) Table 252. SAMEA Oseltamivir Phosphate Antiviral Drug Sales Price by Application (2021-2026) & (US$/unit) Table 253. SAMEA Oseltamivir Phosphate Antiviral Drug Sales Price by Application (2027-2032) & (US$/unit) Table 254. SAMEA Oseltamivir Phosphate Antiviral Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 255. SAMEA Oseltamivir Phosphate Antiviral Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 256. SAMEA Oseltamivir Phosphate Antiviral Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 257. SAMEA Oseltamivir Phosphate Antiviral Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 258. SAMEA Oseltamivir Phosphate Antiviral Drug Sales by Country (2021-2026) & (k units) Table 259. SAMEA Oseltamivir Phosphate Antiviral Drug Sales by Country (2027-2032) & (k units) Table 260. SAMEA Oseltamivir Phosphate Antiviral Drug Sales Price by Country (2021-2026) & (US$/unit) Table 261. SAMEA Oseltamivir Phosphate Antiviral Drug Sales Price by Country (2027-2032) & (US$/unit) Table 262. Brazil Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Table 263. Argentina Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Table 264. Chile Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Table 265. Colombia Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Table 266. Peru Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Table 267. Saudi Arabia Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Table 268. Israel Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Table 269. UAE Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Table 270. Turkey Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Table 271. Iran Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Table 272. Egypt Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Table 273. Key Raw Materials Table 274. Raw Materials Key Suppliers Table 275. Oseltamivir Phosphate Antiviral Drug Distributors List Table 276. Oseltamivir Phosphate Antiviral Drug Customers List Table 277. Research Programs/Design for This Report Table 278. Authors List of This Report Table 279. Secondary Sources Table 280. Primary Sources List of Figures Figure 1. Oseltamivir Phosphate Antiviral Drug Image Figure 2. Global Oseltamivir Phosphate Antiviral Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oseltamivir Phosphate Antiviral Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Capsule Image Figure 5. Suspension Image Figure 6. Global Oseltamivir Phosphate Antiviral Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Oseltamivir Phosphate Antiviral Drug Market Size Share 2021 VS 2025 VS 2032 Figure 8. Child Image Figure 9. Aldult Image Figure 10. Global Oseltamivir Phosphate Antiviral Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Oseltamivir Phosphate Antiviral Drug Revenue (2021-2032) & (US$ Million) Figure 12. Global Oseltamivir Phosphate Antiviral Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Region (2021-2032) Figure 15. Global Oseltamivir Phosphate Antiviral Drug Sales (2021-2032) & (k units) Figure 16. Global Oseltamivir Phosphate Antiviral Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Oseltamivir Phosphate Antiviral Drug Sales YoY (2021-2032) & (k units) Figure 19. Europe Oseltamivir Phosphate Antiviral Drug Sales YoY (2021-2032) & (k units) Figure 20. China Oseltamivir Phosphate Antiviral Drug Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) Oseltamivir Phosphate Antiviral Drug Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa Oseltamivir Phosphate Antiviral Drug Sales YoY (2021-2032) & (k units) Figure 23. Global Oseltamivir Phosphate Antiviral Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Oseltamivir Phosphate Antiviral Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Oseltamivir Phosphate Antiviral Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Type (2021-2032) Figure 29. Global Oseltamivir Phosphate Antiviral Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Type (2021-2032) Figure 32. Global Oseltamivir Phosphate Antiviral Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Application (2021-2032) Figure 35. Global Oseltamivir Phosphate Antiviral Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Application (2021-2032) Figure 38. North America Oseltamivir Phosphate Antiviral Drug Revenue Share by Type (2021-2032) Figure 39. North America Oseltamivir Phosphate Antiviral Drug Sales Share by Type (2021-2032) Figure 40. North America Oseltamivir Phosphate Antiviral Drug Revenue Share by Application (2021-2032) Figure 41. North America Oseltamivir Phosphate Antiviral Drug Sales Share by Application (2021-2032) Figure 42. North America Oseltamivir Phosphate Antiviral Drug Revenue Share by Country (2021-2032) Figure 43. North America Oseltamivir Phosphate Antiviral Drug Sales Share by Country (2021-2032) Figure 44. Europe Oseltamivir Phosphate Antiviral Drug Revenue Share by Type (2021-2032) Figure 45. Europe Oseltamivir Phosphate Antiviral Drug Sales Share by Type (2021-2032) Figure 46. Europe Oseltamivir Phosphate Antiviral Drug Revenue Share by Application (2021-2032) Figure 47. Europe Oseltamivir Phosphate Antiviral Drug Sales Share by Application (2021-2032) Figure 48. Europe Oseltamivir Phosphate Antiviral Drug Revenue Share by Country (2021-2032) Figure 49. Europe Oseltamivir Phosphate Antiviral Drug Sales Share by Country (2021-2032) Figure 50. China Oseltamivir Phosphate Antiviral Drug Revenue Share by Type (2021-2032) Figure 51. China Oseltamivir Phosphate Antiviral Drug Sales Share by Type (2021-2032) Figure 52. China Oseltamivir Phosphate Antiviral Drug Revenue Share by Application (2021-2032) Figure 53. China Oseltamivir Phosphate Antiviral Drug Sales Share by Application (2021-2032) Figure 54. Asia Oseltamivir Phosphate Antiviral Drug Revenue Share by Type (2021-2032) Figure 55. Asia Oseltamivir Phosphate Antiviral Drug Sales Share by Type (2021-2032) Figure 56. Asia Oseltamivir Phosphate Antiviral Drug Revenue Share by Application (2021-2032) Figure 57. Asia Oseltamivir Phosphate Antiviral Drug Sales Share by Application (2021-2032) Figure 58. Asia Oseltamivir Phosphate Antiviral Drug Revenue Share by Country (2021-2032) Figure 59. Asia Oseltamivir Phosphate Antiviral Drug Sales Share by Country (2021-2032) Figure 60. SAMEA Oseltamivir Phosphate Antiviral Drug Revenue Share by Type (2021-2032) Figure 61. SAMEA Oseltamivir Phosphate Antiviral Drug Sales Share by Type (2021-2032) Figure 62. SAMEA Oseltamivir Phosphate Antiviral Drug Revenue Share by Application (2021-2032) Figure 63. SAMEA Oseltamivir Phosphate Antiviral Drug Sales Share by Application (2021-2032) Figure 64. SAMEA Oseltamivir Phosphate Antiviral Drug Revenue Share by Country (2021-2032) Figure 65. SAMEA Oseltamivir Phosphate Antiviral Drug

Scope & coverage.

Types
  • Capsule
  • Suspension
Applications
  • Child
  • Aldult
Companies covered
  • Teva Pharmaceuticals
  • SL Pharmaceutica
  • Cspc Holdings
  • Roche Group
  • Kelun Pharmaceutical
  • HEC ChangJiang Pharmaceutical
  • BrightGene Bio-Medical Technology
  • Zydus Cadila
  • Strides Pharma Inc.
  • Novadoz
  • Natco Pharma
  • Macleods Pharmaceuticals
  • LUPINE Limited
  • Hetero Group
  • Camber Pharmaceuticals
  • Amneal Pharmaceuticals
  • Alvogen
  • Alembic Pharmaceuticals
  • Ajanta Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Oseltamivir Phosphate Antiviral Drug Market by Type
  3. 1.2.1 Global Oseltamivir Phosphate Antiviral Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Capsule
  5. 1.2.3 Suspension
  6. 1.3 Oseltamivir Phosphate Antiviral Drug Market by Application
  7. 1.3.1 Global Oseltamivir Phosphate Antiviral Drug Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Child
  9. 1.3.3 Aldult
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Oseltamivir Phosphate Antiviral Drug Market Dynamics
  1. 2.1 Oseltamivir Phosphate Antiviral Drug Industry Trends
  2. 2.2 Oseltamivir Phosphate Antiviral Drug Industry Drivers
  3. 2.3 Oseltamivir Phosphate Antiviral Drug Industry Opportunities and Challenges
  4. 2.4 Oseltamivir Phosphate Antiviral Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Oseltamivir Phosphate Antiviral Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Oseltamivir Phosphate Antiviral Drug Revenue by Region
  3. 3.2.1 Global Oseltamivir Phosphate Antiviral Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Oseltamivir Phosphate Antiviral Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Oseltamivir Phosphate Antiviral Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Oseltamivir Phosphate Antiviral Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Oseltamivir Phosphate Antiviral Drug Sales by Region
  9. 3.4.1 Global Oseltamivir Phosphate Antiviral Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Oseltamivir Phosphate Antiviral Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Oseltamivir Phosphate Antiviral Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Oseltamivir Phosphate Antiviral Drug Revenue by Manufacturers
  2. 4.1.1 Global Oseltamivir Phosphate Antiviral Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Oseltamivir Phosphate Antiviral Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Oseltamivir Phosphate Antiviral Drug Sales by Manufacturers
  6. 4.2.1 Global Oseltamivir Phosphate Antiviral Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Oseltamivir Phosphate Antiviral Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Oseltamivir Phosphate Antiviral Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Oseltamivir Phosphate Antiviral Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Oseltamivir Phosphate Antiviral Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Oseltamivir Phosphate Antiviral Drug Manufacturers, Product Type & Application
  13. 4.7 Global Oseltamivir Phosphate Antiviral Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Oseltamivir Phosphate Antiviral Drug Market CR5 and HHI
  16. 4.8.2 2025 Oseltamivir Phosphate Antiviral Drug Tier 1, Tier 2, and Tier 3
5 Oseltamivir Phosphate Antiviral Drug Market by Type
  1. 5.1 Global Oseltamivir Phosphate Antiviral Drug Revenue by Type
  2. 5.1.1 Global Oseltamivir Phosphate Antiviral Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Oseltamivir Phosphate Antiviral Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Oseltamivir Phosphate Antiviral Drug Sales by Type
  6. 5.2.1 Global Oseltamivir Phosphate Antiviral Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Oseltamivir Phosphate Antiviral Drug Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Oseltamivir Phosphate Antiviral Drug Price by Type
6 Oseltamivir Phosphate Antiviral Drug Market by Application
  1. 6.1 Global Oseltamivir Phosphate Antiviral Drug Revenue by Application
  2. 6.1.1 Global Oseltamivir Phosphate Antiviral Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Oseltamivir Phosphate Antiviral Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Oseltamivir Phosphate Antiviral Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Oseltamivir Phosphate Antiviral Drug Sales by Application
  6. 6.2.1 Global Oseltamivir Phosphate Antiviral Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Oseltamivir Phosphate Antiviral Drug Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Oseltamivir Phosphate Antiviral Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Oseltamivir Phosphate Antiviral Drug Price by Application
7 Company Profiles
  1. 7.1 Teva Pharmaceuticals
  2. 7.1.1 Teva Pharmaceuticals Company Information
  3. 7.1.2 Teva Pharmaceuticals Business Overview
  4. 7.1.3 Teva Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio
  6. 7.1.5 Teva Pharmaceuticals Recent Developments
  7. 7.2 SL Pharmaceutica
  8. 7.2.1 SL Pharmaceutica Company Information
  9. 7.2.2 SL Pharmaceutica Business Overview
  10. 7.2.3 SL Pharmaceutica Oseltamivir Phosphate Antiviral Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 SL Pharmaceutica Oseltamivir Phosphate Antiviral Drug Product Portfolio
  12. 7.2.5 SL Pharmaceutica Recent Developments
  13. 7.3 Cspc Holdings
  14. 7.3.1 Cspc Holdings Company Information
  15. 7.3.2 Cspc Holdings Business Overview
  16. 7.3.3 Cspc Holdings Oseltamivir Phosphate Antiviral Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Cspc Holdings Oseltamivir Phosphate Antiviral Drug Product Portfolio
  18. 7.3.5 Cspc Holdings Recent Developments
  19. 7.4 Roche Group
  20. 7.4.1 Roche Group Company Information
  21. 7.4.2 Roche Group Business Overview
  22. 7.4.3 Roche Group Oseltamivir Phosphate Antiviral Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Roche Group Oseltamivir Phosphate Antiviral Drug Product Portfolio
  24. 7.4.5 Roche Group Recent Developments
  25. 7.5 Kelun Pharmaceutical
  26. 7.5.1 Kelun Pharmaceutical Company Information
  27. 7.5.2 Kelun Pharmaceutical Business Overview
  28. 7.5.3 Kelun Pharmaceutical Oseltamivir Phosphate Antiviral Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Kelun Pharmaceutical Oseltamivir Phosphate Antiviral Drug Product Portfolio
  30. 7.5.5 Kelun Pharmaceutical Recent Developments
  31. 7.6 HEC ChangJiang Pharmaceutical
  32. 7.6.1 HEC ChangJiang Pharmaceutical Company Information
  33. 7.6.2 HEC ChangJiang Pharmaceutical Business Overview
  34. 7.6.3 HEC ChangJiang Pharmaceutical Oseltamivir Phosphate Antiviral Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 HEC ChangJiang Pharmaceutical Oseltamivir Phosphate Antiviral Drug Product Portfolio
  36. 7.6.5 HEC ChangJiang Pharmaceutical Recent Developments
  37. 7.7 BrightGene Bio-Medical Technology
  38. 7.7.1 BrightGene Bio-Medical Technology Company Information
  39. 7.7.2 BrightGene Bio-Medical Technology Business Overview
  40. 7.7.3 BrightGene Bio-Medical Technology Oseltamivir Phosphate Antiviral Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 BrightGene Bio-Medical Technology Oseltamivir Phosphate Antiviral Drug Product Portfolio
  42. 7.7.5 BrightGene Bio-Medical Technology Recent Developments
  43. 7.8 Zydus Cadila
  44. 7.8.1 Zydus Cadila Company Information
  45. 7.8.2 Zydus Cadila Business Overview
  46. 7.8.3 Zydus Cadila Oseltamivir Phosphate Antiviral Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Zydus Cadila Oseltamivir Phosphate Antiviral Drug Product Portfolio
  48. 7.8.5 Zydus Cadila Recent Developments
  49. 7.9 Strides Pharma Inc.
  50. 7.9.1 Strides Pharma Inc. Company Information
  51. 7.9.2 Strides Pharma Inc. Business Overview
  52. 7.9.3 Strides Pharma Inc. Oseltamivir Phosphate Antiviral Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Strides Pharma Inc. Oseltamivir Phosphate Antiviral Drug Product Portfolio
  54. 7.9.5 Strides Pharma Inc. Recent Developments
  55. 7.10 Novadoz
  56. 7.10.1 Novadoz Company Information
  57. 7.10.2 Novadoz Business Overview
  58. 7.10.3 Novadoz Oseltamivir Phosphate Antiviral Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Novadoz Oseltamivir Phosphate Antiviral Drug Product Portfolio
  60. 7.10.5 Novadoz Recent Developments
  61. 7.11 Natco Pharma
  62. 7.11.1 Natco Pharma Company Information
  63. 7.11.2 Natco Pharma Business Overview
  64. 7.11.3 Natco Pharma Oseltamivir Phosphate Antiviral Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Natco Pharma Oseltamivir Phosphate Antiviral Drug Product Portfolio
  66. 7.11.5 Natco Pharma Recent Developments
  67. 7.12 Macleods Pharmaceuticals
  68. 7.12.1 Macleods Pharmaceuticals Company Information
  69. 7.12.2 Macleods Pharmaceuticals Business Overview
  70. 7.12.3 Macleods Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Macleods Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio
  72. 7.12.5 Macleods Pharmaceuticals Recent Developments
  73. 7.13 LUPINE Limited
  74. 7.13.1 LUPINE Limited Company Information
  75. 7.13.2 LUPINE Limited Business Overview
  76. 7.13.3 LUPINE Limited Oseltamivir Phosphate Antiviral Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 LUPINE Limited Oseltamivir Phosphate Antiviral Drug Product Portfolio
  78. 7.13.5 LUPINE Limited Recent Developments
  79. 7.14 Hetero Group
  80. 7.14.1 Hetero Group Company Information
  81. 7.14.2 Hetero Group Business Overview
  82. 7.14.3 Hetero Group Oseltamivir Phosphate Antiviral Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Hetero Group Oseltamivir Phosphate Antiviral Drug Product Portfolio
  84. 7.14.5 Hetero Group Recent Developments
  85. 7.15 Camber Pharmaceuticals
  86. 7.15.1 Camber Pharmaceuticals Company Information
  87. 7.15.2 Camber Pharmaceuticals Business Overview
  88. 7.15.3 Camber Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Camber Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio
  90. 7.15.5 Camber Pharmaceuticals Recent Developments
  91. 7.16 Amneal Pharmaceuticals
  92. 7.16.1 Amneal Pharmaceuticals Company Information
  93. 7.16.2 Amneal Pharmaceuticals Business Overview
  94. 7.16.3 Amneal Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Amneal Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio
  96. 7.16.5 Amneal Pharmaceuticals Recent Developments
  97. 7.17 Alvogen
  98. 7.17.1 Alvogen Company Information
  99. 7.17.2 Alvogen Business Overview
  100. 7.17.3 Alvogen Oseltamivir Phosphate Antiviral Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Alvogen Oseltamivir Phosphate Antiviral Drug Product Portfolio
  102. 7.17.5 Alvogen Recent Developments
  103. 7.18 Alembic Pharmaceuticals
  104. 7.18.1 Alembic Pharmaceuticals Company Information
  105. 7.18.2 Alembic Pharmaceuticals Business Overview
  106. 7.18.3 Alembic Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Alembic Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product Portfolio
  108. 7.18.5 Alembic Pharmaceuticals Recent Developments
  109. 7.19 Ajanta Pharma
  110. 7.19.1 Ajanta Pharma Company Information
  111. 7.19.2 Ajanta Pharma Business Overview
  112. 7.19.3 Ajanta Pharma Oseltamivir Phosphate Antiviral Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Ajanta Pharma Oseltamivir Phosphate Antiviral Drug Product Portfolio
  114. 7.19.5 Ajanta Pharma Recent Developments
8 North America
  1. 8.1 North America Oseltamivir Phosphate Antiviral Drug Market Size by Type
  2. 8.1.1 North America Oseltamivir Phosphate Antiviral Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Oseltamivir Phosphate Antiviral Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Oseltamivir Phosphate Antiviral Drug Price by Type (2021-2032)
  5. 8.2 North America Oseltamivir Phosphate Antiviral Drug Market Size by Application
  6. 8.2.1 North America Oseltamivir Phosphate Antiviral Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Oseltamivir Phosphate Antiviral Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Oseltamivir Phosphate Antiviral Drug Price by Application (2021-2032)
  9. 8.3 North America Oseltamivir Phosphate Antiviral Drug Market Size by Country
  10. 8.3.1 North America Oseltamivir Phosphate Antiviral Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Oseltamivir Phosphate Antiviral Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Oseltamivir Phosphate Antiviral Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Oseltamivir Phosphate Antiviral Drug Market Size by Type
  2. 9.1.1 Europe Oseltamivir Phosphate Antiviral Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Oseltamivir Phosphate Antiviral Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Oseltamivir Phosphate Antiviral Drug Price by Type (2021-2032)
  5. 9.2 Europe Oseltamivir Phosphate Antiviral Drug Market Size by Application
  6. 9.2.1 Europe Oseltamivir Phosphate Antiviral Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Oseltamivir Phosphate Antiviral Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Oseltamivir Phosphate Antiviral Drug Price by Application (2021-2032)
  9. 9.3 Europe Oseltamivir Phosphate Antiviral Drug Market Size by Country
  10. 9.3.1 Europe Oseltamivir Phosphate Antiviral Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Oseltamivir Phosphate Antiviral Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Oseltamivir Phosphate Antiviral Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Oseltamivir Phosphate Antiviral Drug Market Size by Type
  2. 10.1.1 China Oseltamivir Phosphate Antiviral Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Oseltamivir Phosphate Antiviral Drug Sales by Type (2021-2032)
  4. 10.1.3 China Oseltamivir Phosphate Antiviral Drug Price by Type (2021-2032)
  5. 10.2 China Oseltamivir Phosphate Antiviral Drug Market Size by Application
  6. 10.2.1 China Oseltamivir Phosphate Antiviral Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Oseltamivir Phosphate Antiviral Drug Sales by Application (2021-2032)
  8. 10.2.3 China Oseltamivir Phosphate Antiviral Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Oseltamivir Phosphate Antiviral Drug Market Size by Type
  2. 11.1.1 Asia Oseltamivir Phosphate Antiviral Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Oseltamivir Phosphate Antiviral Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Oseltamivir Phosphate Antiviral Drug Price by Type (2021-2032)
  5. 11.2 Asia Oseltamivir Phosphate Antiviral Drug Market Size by Application
  6. 11.2.1 Asia Oseltamivir Phosphate Antiviral Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Oseltamivir Phosphate Antiviral Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Oseltamivir Phosphate Antiviral Drug Price by Application (2021-2032)
  9. 11.3 Asia Oseltamivir Phosphate Antiviral Drug Market Size by Country
  10. 11.3.1 Asia Oseltamivir Phosphate Antiviral Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Oseltamivir Phosphate Antiviral Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Oseltamivir Phosphate Antiviral Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Oseltamivir Phosphate Antiviral Drug Market Size by Type
  2. 12.1.1 SAMEA Oseltamivir Phosphate Antiviral Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Oseltamivir Phosphate Antiviral Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Oseltamivir Phosphate Antiviral Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Oseltamivir Phosphate Antiviral Drug Market Size by Application
  6. 12.2.1 SAMEA Oseltamivir Phosphate Antiviral Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Oseltamivir Phosphate Antiviral Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Oseltamivir Phosphate Antiviral Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Oseltamivir Phosphate Antiviral Drug Market Size by Country
  10. 12.3.1 SAMEA Oseltamivir Phosphate Antiviral Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Oseltamivir Phosphate Antiviral Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Oseltamivir Phosphate Antiviral Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Oseltamivir Phosphate Antiviral Drug Value Chain Analysis
  2. 13.1.1 Oseltamivir Phosphate Antiviral Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Oseltamivir Phosphate Antiviral Drug Production Mode & Process
  6. 13.2 Oseltamivir Phosphate Antiviral Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Oseltamivir Phosphate Antiviral Drug Distributors
  9. 13.2.3 Oseltamivir Phosphate Antiviral Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst